Clozapine: An Updated Overview of Pharmacogenetic Biomarkers, Risks, and Safety—Particularities in the Context of COVID-19

Background: clozapine (CLZ) use is precarious due to its neurological, cardiovascular, and hematological side effects; however, it is the gold standard in therapy-resistant schizophrenia (TRS) in adults and is underused. Objective: to examine the most recent CLZ data on (a) side effects concerning (...

Descripción completa

Detalles Bibliográficos
Autores principales: Dragoi, Ana Miruna, Radulescu, Ioana, Năsui, Bogdana Adriana, Pop, Anca Lucia, Varlas, Valentin Nicolae, Trifu, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697202/
https://www.ncbi.nlm.nih.gov/pubmed/33187329
http://dx.doi.org/10.3390/brainsci10110840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697202/
https://www.ncbi.nlm.nih.gov/pubmed/33187329
http://dx.doi.org/10.3390/brainsci10110840

Ejemplares similares